The lack of additional masses or lymphadenopathy on imaging and the identification of the same clonal CD8-positive T-cell LPD in all sampled sites of disease (brain, CSF and bone marrow) indicates that this clonal CD8-positive T-cell proliferation was indeed the predominant pathological feature. The gene discussed is CD8A; the disease is Lymphadenopathy.